American drug officials warned Canada about Oxy generics
News | 07 December 2012
Pharmacists, medical groups and provincial governments also raised concerns, but six major drug companies were allowed to start producing generic Oxy last Monday following a scientific review by Health Canada. Aboriginal leaders in northern Ontario ...
Click on the link to read the full article at Sun News Network
(This link will open in a new window)
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- US FDA advisory panel backs approval of Merck & Co's suvorexant, but only at lower doses
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
